A Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination with Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis

Trial Profile

A Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination with Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Belimumab (Primary) ; Azathioprine
  • Indications Microscopic polyangiitis; Wegener's granulomatosis
  • Focus Registrational; Therapeutic Use
  • Acronyms BREVAS
  • Sponsors Human Genome Sciences
  • Most Recent Events

    • 09 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 29 Nov 2016 This trial has been completed in Poland.
    • 05 Oct 2016 This trial was completed in Czech Republic, according to European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top